Cargando…

IL-21 Modulates Activation of NKT Cells in Patients with Stage IV Malignant Melanoma

Interleukin-21 (IL-21) is a common γ-chain cytokine produced by T helper and natural killer T (NKT) cells. It has been shown to regulate the response of various lymphocyte subsets including NK, NKT, T and B cells. Owing to its potent anti-tumor function in preclinical studies and its ability to indu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coquet, Jonathan M, Skak, Kresten, Davis, Ian D, Smyth, Mark J, Godfrey, Dale I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232058/ https://www.ncbi.nlm.nih.gov/pubmed/25505948 http://dx.doi.org/10.1038/cti.2013.7

Ejemplares similares

Differential antitumor immunity mediated by NKT cell subsets in vivo
por: Crowe, Nadine Y., et al.
Publicado: (2005)

IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinoma
por: Frederiksen, Klaus Stensgaard, et al.
Publicado: (2008)

New ways to turn on NKT cells
por: Godfrey, Dale Ian, et al.
Publicado: (2011)

Electrochemotherapy Plus IL-2+IL-12 Gene Electrotransfer in Spontaneous Inoperable Stage III–IV Canine Oral Malignant Melanoma
por: Tellado, Matías, et al.
Publicado: (2023)

Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer
por: Smyth, Mark J., et al.
Publicado: (2005)

IL-21 regulates germinal center B cell differentiation and proliferation through a B cell–intrinsic mechanism
por: Zotos, Dimitra, et al.
Publicado: (2010)

Activation of Invariant NKT Cells Exacerbates Experimental Visceral Leishmaniasis
por: Stanley, Amanda C., et al.
Publicado: (2008)

Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
por: Smyth, Mark J., et al.
Publicado: (2000)

A Natural Killer T (NKT) Cell Developmental Pathway Involving a Thymus-dependent NK1.1(−)CD4(+) CD1d-dependent Precursor Stage
por: Pellicci, Daniel G., et al.
Publicado: (2002)

IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate
por: Le, Thuy T., et al.
Publicado: (2016)

Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients
por: Atzpodien, J, et al.
Publicado: (2007)

Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma
por: Bjørn, Jon, et al.
Publicado: (2013)

Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect
por: Prasit, Kef K, et al.
Publicado: (2022)

The cost of unresectable stage III or stage IV melanoma in Italy
por: Maio, Michele, et al.
Publicado: (2012)

Antigen-specific human NKT cells from tuberculosis patients produce IL-21 to help B cells for the production of immunoglobulins
por: Wu, Changyou, et al.
Publicado: (2015)

NKT cell adjuvants in therapeutic vaccines against hematological cancers
por: Mattarollo, Stephen R., et al.
Publicado: (2013)

Ingenol Disoxate: A Novel 4-Isoxazolecarboxylate Ester of Ingenol with Improved Properties for Treatment of Actinic Keratosis and Other Non-Melanoma Skin Cancers
por: Bertelsen, Malene, et al.
Publicado: (2016)

Differential Requirement for the CD45 Splicing Regulator hnRNPLL for Accumulation of NKT and Conventional T Cells
por: Yabas, Mehmet, et al.
Publicado: (2011)

NKT cell status and IL-10-dependent therapeutic effect of NKT cell stimulation on collagen-arthritis in DBA/1 mice
por: Bessis, N, et al.
Publicado: (2005)

Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2
por: Khong, Brian, et al.
Publicado: (2018)

Characterization of the early stages of thymic NKT cell development
por: Benlagha, Kamel, et al.
Publicado: (2005)

α/β–T Cell Receptor (TCR)(+)CD4(−)CD8(−) (NKT) Thymocytes Prevent Insulin-dependent Diabetes Mellitus in Nonobese Diabetic (NOD)/Lt Mice by the Influence of Interleukin (IL)-4 and/or IL-10
por: Hammond, Kirsten J.L., et al.
Publicado: (1998)

Invariant NKT cells modulate the suppressive activity of Serum Amyloid A-differentiated IL-10-secreting neutrophils
por: De Santo, Carmela, et al.
Publicado: (2010)

β-Catenin is required for the differentiation of iNKT2 and iNKT17 cells that augment IL-25-dependent lung inflammation
por: Berga-Bolaños, Rosa, et al.
Publicado: (2015)

YY1(lo) NKT cells are dedicated IL-10 producers
por: Darcy, Patrick W., et al.
Publicado: (2020)

MiR-21: an environmental driver of malignant melanoma?
por: Melnik, Bodo C
Publicado: (2015)

Harnessing NKT cells for vaccination
por: Burn, Olivia K, et al.
Publicado: (2021)

SOX chemotherapy with anti-PD-1 and iNKT cell immunotherapies for stage IV gastric adenocarcinoma with liver metastases: A case report
por: Li, Dezhao, et al.
Publicado: (2022)

IL-12 and IL-18 Induction and Subsequent NKT Activation Effects of the Japanese Botanical Medicine Juzentaihoto
por: Fujiki, Kazuhiko, et al.
Publicado: (2008)

Are NKT cells a useful predictor of COVID-19 severity?
por: Koay, Hui-Fern, et al.
Publicado: (2022)

NK and NKT Cell-Mediated Immune Surveillance against Hematological Malignancies
por: Shimizu, Kanako, et al.
Publicado: (2020)

BATF regulates the development and function of IL-17 producing iNKT cells
por: Jordan-Williams, Kimberly L, et al.
Publicado: (2013)

Patients presenting with stage IV uveal melanoma: Lessons learned
por: Garg, Gaurav, et al.
Publicado: (2022)

The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells
por: Kitamura, Hidemitsu, et al.
Publicado: (1999)

The Timing and Abundance of IL-2Rβ (CD122) Expression Control Thymic iNKT Cell Generation and NKT1 Subset Differentiation
por: Won, Hee Yeun, et al.
Publicado: (2021)

NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20
por: Drennan, Michael B., et al.
Publicado: (2016)

A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance
por: Terabe, Masaki, et al.
Publicado: (2005)

Trained Immunity of IL-12-, IL-15-, and IL-18-Induced CD(3)+CD(56)+ NKT-Like Cells
por: Zhu, Siyu, et al.
Publicado: (2022)

Modulation of human Vα24(+)Vβ11(+) NKT cells by age, malignancy and conventional anticancer therapies
por: Crough, T, et al.
Publicado: (2004)

Differential location of NKT and MAIT cells within lymphoid tissue
por: Johnson, Darryl N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b7ctqg472su946ge64apkcpvdl